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We studied the effect of oral administration of 25(OH) vitamin D3 (10 f.Lg daily, for the first wk oflife) on plasma calcium levels of preterm babies with clinical characteristics similar to Salle's ones.
Our data given in the following show that 25(OH) vitamin D3 was not able to modify significantly the daily mean plasma calcium levels in premature infants. But we observed a decrease in the incidence of early hypocalcemia, though this difference was not significant. Comparing our data with that of Salle, we would emphasize that the higher mean plasma calcium levels and the lower incidence of early hypocalcemia probably depend on feeding pattern: human or humanized milk was commenced at 1 h of age in all our infants.
In fact, in a previous experience we pointed out that the incidence of hypocalcemia decreased from 48.02% in preterm infants in whom a milk diet was commenced at 6-12 h of age, to 22.58% in premature infants fed with humanized milk at 1 h (P
